
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses methods to overcome the challenge of high out-of-pocket costs that can have a negative impact on patient medication adherence.
Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses methods to overcome the challenge of high out-of-pocket costs that can have a negative impact on patient medication adherence.




